Skip to main content
. 2024 Jun 2;16:17588359241253115. doi: 10.1177/17588359241253115

Figure 8.

Figure 8.

Incidence rate ratios (and 95% confidence intervals) of endocrine treatment-related outcomes (bisphosphonates) in prostate cancer patients on endocrine treatments in the post-lockdown periods compared to pre-pandemic rates.

Dashed line indicates start of pandemic. Lockdown periods defined as: lockdown (March 2020–June 2020); post-first lockdown (July 2020–October 2020); second lockdown (November 2020–December 2020); third lockdown (January 2021–March 2021); easing of restrictions (April 2021–June 2021) and most legal restrictions removed (July 2021–June 2022).